Citations 4
Tocilizumab as Add-on Therapy for Severe Attacks in NMOSD and MOGAD: A Multicenter Retrospective Case Series (P3-1.009)
Flanagan, Eoin P., Vilaseca, Andreu, Bilodeau, Philippe-Antoine, Jiang, Mulan , Said, Yana , Chen, Haiwen , Chen, John J., Pittock, Sean J., Sotirchos, Elias, Levy, Michael, Flanagan, Eoin P. , Vilaseca, Andreu , Bilodeau, Philippe-Antoine, Filippatou, Angeliki , Pittock, Sean J. , Sotirchos, Elias S. , Levy, Michael , Kister, Ilya
Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available
A Comparative Clinical Effectiveness Trial of Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab to Prevent Relapses in Neuromyelitis Optica Spectrum Disorder (NMOSD) (P3-1.001)
Bilodeau, Philippe-Antoine, Devlin, Michael, Bhattacharyya, Shamik, Salky, Rebecca, Mendoza, Juan Sebastian, Friede, Tim, Bennett, Jeffrey, Cree, Bruce, Palace, Jacqueline, Levy, Michael, Fujihara, Kazuo, Kim, Ho Jin, Flanagan, Eoin , Matiello, Marcelo, Paul, Friedemann, Vishnevetsky, Anastasia , Bhattacharyya, Shamik , Friede, Tim , Cree, Bruce , Palace, Jacqueline , Levy, Michael , Fujihara, Kazuo , Kim, Ho Jin , Flanagan, Eoin P. , Matiello, Marcelo , Paul, Friedemann
Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available
Safety and Efficacy of Satralizumab in Patients with Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD): Results from the Phase 3 METEOROID Trial (PL5.006)
Levy, Michael, Flanagan, Eoin , Kümpfel, Tania, Marignier, Romain, Fujihara, Kazuo, Hemingway, Cheryl, Stokmaier, Daniela, Klingelschmitt, Gaëlle, Büdingen, H.-Christian von, TANAKA, SAYURI, Friedemann, Paul, Levy, Michael , Flanagan, Eoin P. , Kümpfel, Tania , Marignier, Romain , Fujihara, Kazuo , Hemingway, Cheryl , Büdingen, H.-Christian von, Li, Li
Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available
Long-term Efficacy and Safety of Ravulizumab in Anti-aquaporin-4 Antibody-positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD): Final Analysis of the Phase 3 CHAMPION-NMOSD Trial (P7-1.012)
Pittock, Sean, Barnett, Michael, Bennett, Jeffrey, Berthele, Achim, Seze, Jérôme de, Levy, Michael, Oreja-Guevara, Celia, Palace, Jacqueline, Paul, Friedemann, Allen, Kerstin, Parks, Becky, Kim, Ho Jin, Pittock, Sean J. , Barnett, Michael , Bennett, Jeffrey, Berthele, Achim , Seze, Jerome De , Levy, Michael , Nakashima, Ichiro , Oreja‐Guevara, Celia , Palace, Jacqueline , Paul, Friedemann , Pozzilli, Carlo , Allen, Kerstin , Parks, Becky , Kim, Ho Jin
Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available